NKTR Nektar Therapeutics
Healthcare$66.58+0.00%OpenMarket Cap: $1.30B
As of 2026-05-26
Analyst Consensus
Consensus
Buy
Target (Consensus)
$149.60
Target (Median)
$151.00
Target Range
$80.00 - $192.00
Upside from current price: 124.7%
Rating Distribution
1 Strong Buy8 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2026-05-11 | Wedbush | maintain | Neutral | Neutral |
| 2026-05-08 | Piper Sandler | maintain | Overweight | Overweight |
| 2026-04-21 | Citigroup | maintain | Buy | Buy |
| 2026-04-20 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-04-20 | BTIG | maintain | Buy | Buy |
| 2026-03-16 | Citigroup | maintain | Buy | Buy |
| 2026-02-23 | B. Riley Securities | maintain | Buy | Buy |
| 2026-02-10 | HC Wainwright & Co. | maintain | Buy | Buy |
| 2026-02-10 | BTIG | maintain | Buy | Buy |
| 2025-12-16 | BTIG | maintain | Buy | Buy |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $-11.07 | $36.9M | 7 |
| Sun Dec 31 | $-11.40 | $52.4M | 9 |
| Mon Dec 31 | $-10.61 | $94.8M | 3 |
| Tue Dec 31 | $-8.02 | $199.2M | 3 |